SCHEMBL21737951

SCHEMBL21737951

Brc1nnc(N2CCCCC2)s1

nearest known ligand 0.61

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.61
GAA P10253 2/20 0.61
HSD17B10 Q99714 2/20 0.61
MAPK1 P28482 1/20 0.61
HRH3 Q9Y5N1 10/20 0.41
RAB9A P51151 2/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21725122 0.98 ALDH1A1 (0.57) ALDH1A1GAAHSD17B10MAPK1HRH3
SCHEMBL2377170 0.82 HRH3 (0.64) HRH3
SCHEMBL25859539 0.78 RAB9A (0.42) ALDH1A1GAAHSD17B10MAPK1RAB9A
SCHEMBL31492979 0.78 TDP1 (0.43) ALDH1A1GAAHSD17B10MAPK1RAB9A
SCHEMBL21737993 0.77 GAA (0.38) ALDH1A1GAAHSD17B10MAPK1HRH3
SCHEMBL23975594 0.76 ALDH1A1 (0.59) ALDH1A1GAAHSD17B10MAPK1HRH3
SCHEMBL5631018 0.76 ALDH1A1 (1.00) ALDH1A1GAAHSD17B10MAPK1HRH3
SCHEMBL11372459 0.76 ALDH1A1 (1.00) ALDH1A1GAAHSD17B10MAPK1HRH3
SCHEMBL14479660 0.76 ALDH1A1 (0.59) ALDH1A1GAAHSD17B10MAPK1HRH3
SCHEMBL21738073 0.75 GAA (0.36) ALDH1A1GAAHSD17B10MAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023186069-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 石药集团中奇制药技术(石家庄)有限公司 2023-10-05 WO disclosed
WO-2020036986-A1 THIADIAZOLE IRAK4 INHIBITORS GILEAD SCIENCES, INC. (US) 2020-02-20 WO disclosed